名稱 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocati |
型號 | CBP20188D |
報價 | ![]() |
特點 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocation |
產(chǎn)品搜索
相關(guān)文章
- ATCC細(xì)胞的貼壁過程有何特點呢?
- 基于納米顆粒的組合免疫療法對致命性癌癥發(fā)起三重打擊
- PLoS ONE:科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- 分子診斷標(biāo)準(zhǔn)品,選擇科佰生物
- 泛腫瘤大panel質(zhì)控品升級,免費試用申請中
- 大腦中新發(fā)現(xiàn)的一種淋巴細(xì)胞,能夠清除大腦廢物
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 腫瘤細(xì)胞上的DNA排列方式探討
- 【靶點模型+診斷質(zhì)控】EGFR vIII的藥物開發(fā)和診斷
- 【靶點模型+診斷質(zhì)控】BTK C481S的藥物開發(fā)和診斷
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Translocation > CBP20188DAI-Edigene® FGFR2(E17)- BICC1(E3) Translocati

- 詳細(xì)內(nèi)容
CBP20188D | |
Format | DNA |
Description | FGFR2, fibroblast growth factor receptor 2, is a receptor tyrosine kinase activated upon binding of the FGF ligand, which activates RAS-MAPK and PI3K-AKT pathways. Altered function of FGFR2 through activating mutations, fusions, and amplification increases cell proliferation and tumorigenesis and is observed in prostate, breast, lung, uterine, and ovarian cancers, while FGFR2 amplification and overexpression is commonly observed in gastric cancer. |
Technical Data | |
Left Gene | FGFR2 |
Left Breakpoint | chr10:1232****1:- (hg19) |
Right Gene | BICC1 |
Right Breakpoint | chr10:60****4:+ (hg19) |
%AF | N/A |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">